JEFFREY S EHMKE

Allopathic & Osteopathic Physicians|Emergency Medicine JEFFERSON CITY, MO NPI 1780631978

General Payments — all program years on this page

$1,068.87

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 65
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $379.86 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $379.8620

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
CSL Behring $240.7212
Janssen Pharmaceuticals, Inc $107.946
Acerta Pharma LLC $31.202

By program year

Program yearAmountRecords
2018 $116.378
2019 $211.6017
2020 $15.951
2021 $40.063
2022 $122.796
2023 $182.2410
2024 $379.8620

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078058112 Janssen Pharmaceuticals, Inc $14.66 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078058116 Janssen Pharmaceuticals, Inc $17.34 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078058122 Janssen Pharmaceuticals, Inc $19.70 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078058124 Janssen Pharmaceuticals, Inc $16.11 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078058128 Janssen Pharmaceuticals, Inc $21.08 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078058138 Janssen Pharmaceuticals, Inc $19.05 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104518818 AstraZeneca Pharmaceuticals LP $13.90 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105516977 AstraZeneca Pharmaceuticals LP $17.30 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134599099 CSL Behring $20.70 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134599111 CSL Behring $20.70 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134599119 CSL Behring $18.63 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134599123 CSL Behring $20.17 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134599207 CSL Behring $20.43 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134599211 CSL Behring $25.65 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134599213 CSL Behring $29.97 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134599215 CSL Behring $2.78 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134599223 CSL Behring $26.58 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134599233 CSL Behring $14.93 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134599239 CSL Behring $17.08 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134599243 CSL Behring $23.10 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.